JG
LUMO

Joel Greenblatt’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Joel Greenblatt’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,442
Closed -$313K – 1112
2017
Q1 		$313K Buy
+1,442
New +$206K ﹤0.01% 851
2015
Q3 		– Sell
-138,317
Closed -$55.1M – 1062
2015
Q2 		$55.1M Buy
138,317
+45,181
+49% +$19.2M 0.46% 46
2015
Q1 		$45.9M Buy
+93,136
New +$36.1M 0.35% 98

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Joel Greenblatt's LUMO Position: Q2 2017 in Review

Joel Greenblatt sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2017, closing a stake of 1,442 shares — an estimated $313K sold.

Joel Greenblatt first reported a position in LUMO in Q1 2015 and held it in 3 quarters. The position peaked at $55.1M in Q2 2015. 110 funds tracked by Wall St. Rank hold LUMO as of Q2 2017.

  • Joel Greenblatt reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Joel Greenblatt sold 1,442 Lumos Pharma, Inc. Common Stock shares in Q2 2017, an estimated $313K.
  • Joel Greenblatt first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2015 and held it in 3 quarters.
  • Joel Greenblatt's Lumos Pharma, Inc. Common Stock position peaked at $55.1M in Q2 2015.
  • 110 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2017.

Based on Gotham Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.